According to Sanara MedTech's latest financial reports the company has a price-to-book ratio of 6.31.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 7.96 | -12.12% |
2022-12-31 | 9.06 | 21.08% |
2021-12-31 | 7.48 | -86.09% |
2020-12-31 | 53.8 | 497.92% |
2019-12-31 | 8.99 | -31.69% |
2018-12-31 | 13.2 | -79.95% |
2017-12-31 | 65.7 | -768.28% |
2016-12-31 | -9.83 | 31.58% |
2015-12-31 | -7.47 | 6.28% |
2014-12-31 | -7.03 | 92.84% |
2013-12-31 | -3.64 | 404.04% |
2012-12-31 | -0.7229 | -87.83% |
2011-12-31 | -5.94 | -120.04% |
2010-12-31 | 29.6 | 8.14% |
2009-12-31 | 27.4 | |
2008-12-31 | N/A | |
2007-12-31 | N/A | |
2006-12-31 | N/A | |
2005-12-31 | N/A | |
2004-12-31 | N/A | |
2002-12-31 | -2.89 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.6322 | -89.98% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 1.44 | -77.17% | ๐บ๐ธ USA |